Researchers from MIT and Draper University have developed a 3D Printed Microfluidic Device called Tumor Analysis Platform or TAP that simulates cancer treatments on biopsied cancerous tissue. 3D Printable in about an hour, the Chip device uses the biopsied tumor fragments placement in a chamber connected to a network of deliver fluids to the tissue and contains a new type of biocompatible resin, Pro3dure GR-10 Resin, that can support the long-term survival of biopsied tissue. The TAP is cheap and easy to fabricate and adaptable for clinical use.

Source: http://news.mit.edu/2018/microfluidics-device-tests-cancer-drugs-1212